Abstracts tagged "RCT and vasculitis"

Abstract Number: 1864 • 2014 ACR/ARHP Annual Meeting
Granulomatosis with Polyangiitis or Microscopic Polyangiitis: Long-Term Outcomes of the Prospective Wegent Trial Comparing Azathioprine Vs Methotrexate for Remission-Maintenance in 126 Patients
Xavier Puéchal¹, Christian Pagnoux², Elodie Perrodeau³, Mohamed Hamidou⁴, Jean-Jacques Boffa⁵, Xavier Kyndt⁶, François Lifermann⁷, Thomas Papo⁸, Dominique Merrien⁹, Amar Smail¹⁰, Philippe Delaval¹¹, Catherine Hanrotel-Saliou¹², Bernard Imbert¹³, Chahéra Khouatra¹⁴, Marc Lambert¹⁵, Charles Leské¹⁶, Kim Heang Ly¹⁷, Edouard Pertuiset¹⁸, Pascal Roblot¹⁹, Marc Ruivard²⁰, Jean-François Subra²¹, Jean-Francois Viallard²², Benjamin Terrier¹, Pascal Cohen¹, Luc Mouthon¹, Philippe Ravaud³ and Loïc Guillevin for the French Vasculitis Study Group¹, ¹National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, ²Division of Rheumatology, University of Toronto, Toronto, ON, Canada, ³Epidemiology, Université Paris-Descartes, Paris, Paris, France, ⁴CHU Hôtel Dieu, Nantes, Nantes, France, ⁵Hôpital Tenon, Paris, Paris, France, ⁶Department of Nephrology and Internal Medicine, CH, Valenciennes, Valenciennes, France, ⁷Internal Medicine, CH Côte d'Argent, Dax, Dax, France, ⁸Internal Medicine, Bichat Hospital, Paris, Paris, France, ⁹CH Compiègne-Noyon, Compiègne, France, ¹⁰Internal Medicine Department, CHU Amiens Nord, Amiens, France, ¹¹CHU Rennes Sud, Rennes, France, ¹²CHU Cavale Blanche, Brest, Brest, France, ¹³CHU, Grenoble, Grenoble, France, ¹⁴CHU Louis Pradel, Lyon, Lyon, France, ¹⁵Faculté de Médecine Henri Warembourg, Université Lille Nord de France, Lille, France, ¹⁶CH, Cholet, Cholet, France, ¹⁷CHU Dupuytren, Limoges, Limoges, France, ¹⁸Rheumatology, René Dubos Hospital, Pontoise, France, ¹⁹CHU, Poitiers, Poitiers, France, ²⁰CHU Estaing, Clermont–Ferrand, Clermont–Ferrand, France, ²¹CHU, Angers, Angers, France, ²²Hôpital Haut-Lévêque, Bordeaux, CHU Bordeaux, France
Background/Purpose Results of the previously reported randomized–controlled WEGENT trial demonstrated that, at 28 months, methotrexate (MTX) is as effective as azathioprine (AZA) for maintaining remission…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].